Suppr超能文献

相似文献

1
Biofilm and multidrug resistance in uropathogenic Escherichia coli.
Pathog Glob Health. 2015 Feb;109(1):26-9. doi: 10.1179/2047773215Y.0000000001. Epub 2015 Jan 21.
2
Study of virulence factors of uropathogenic Escherichia coli and its antibiotic susceptibility pattern.
Indian J Pathol Microbiol. 2014 Jan-Mar;57(1):61-4. doi: 10.4103/0377-4929.130899.
4
Association of antibiotic resistance and biofilm formation in Escherichia coli ST131/O25b.
Acta Microbiol Immunol Hung. 2024 Jul 22;71(3):197-205. doi: 10.1556/030.2024.02275. Print 2024 Sep 18.
6
Fosfomycin use in multi drug resistant uropathogenic Escherichia coli.
Infect Disord Drug Targets. 2015;15(3):196-201. doi: 10.2174/1871526515666150916141907.
9
Detection of AmpC β-lactamase and adherence factors in uropathogenic Escherichia coli isolated from aged patients.
Microb Pathog. 2016 Nov;100:293-298. doi: 10.1016/j.micpath.2016.10.010. Epub 2016 Oct 13.

引用本文的文献

1
Serrapeptase Eliminates Biofilms by Targeting Curli Fibers, Lipopolysaccharides, and Phosphate Metabolism.
Microorganisms. 2025 Aug 11;13(8):1875. doi: 10.3390/microorganisms13081875.
3
Bioprospection of Based Products as Quorum Sensing Modulators of SdiA.
Biochem Res Int. 2025 Jun 9;2025:7191508. doi: 10.1155/bri/7191508. eCollection 2025.
5
Fluoroquinolones and Biofilm: A Narrative Review.
Pharmaceuticals (Basel). 2024 Dec 11;17(12):1673. doi: 10.3390/ph17121673.
6
Biofilm Production and Antibiogram Profiles in and Salmonella.
Indian J Microbiol. 2024 Dec;64(4):1512-1517. doi: 10.1007/s12088-023-01149-7. Epub 2023 Dec 9.
7
High-throughput combination assay for studying biofilm formation of uropathogenic Escherichia coli.
Arch Microbiol. 2024 Jul 5;206(8):344. doi: 10.1007/s00203-024-04029-w.
8
Vitamin D and vitamin K1 as novel inhibitors of biofilm in Gram-negative bacteria.
BMC Microbiol. 2024 May 18;24(1):173. doi: 10.1186/s12866-024-03293-6.
9
Clinical Characteristics of Uncomplicated Acute Pyelonephritis Caused by Escherichia coli and Klebsiella pneumoniae.
Infect Dis Ther. 2024 Mar;13(3):581-595. doi: 10.1007/s40121-024-00940-3. Epub 2024 Mar 9.

本文引用的文献

1
In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern.
Asian Pac J Trop Med. 2012 Mar;5(3):210-3. doi: 10.1016/S1995-7645(12)60026-1.
2
Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections.
Indian J Med Microbiol. 2007 Oct;25(4):369-73. doi: 10.4103/0255-0857.37341.
4
Catheter-associated urinary tract infections.
Int J Antimicrob Agents. 2001 Apr;17(4):299-303. doi: 10.1016/s0924-8579(00)00359-9.
5
CAS agar diffusion assay for the measurement of siderophores in biological fluids.
J Microbiol Methods. 2001 Feb 1;44(1):89-95. doi: 10.1016/s0167-7012(00)00229-3.
7
Molecular tools for study of biofilm physiology.
Methods Enzymol. 1999;310:20-42. doi: 10.1016/s0076-6879(99)10004-1.
8
Bacterial biofilms: a common cause of persistent infections.
Science. 1999 May 21;284(5418):1318-22. doi: 10.1126/science.284.5418.1318.
10
Virulence factors in Escherichia coli urinary tract infection.
Clin Microbiol Rev. 1991 Jan;4(1):80-128. doi: 10.1128/CMR.4.1.80.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验